Wolverine Trading, LLC Delcath Systems, Inc. Transaction History
Wolverine Trading, LLC
- $133 Billion
- Q3 2025
A detailed history of Wolverine Trading, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 24,740 shares of DCTH stock, worth $220,928. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,740
Previous 29,800
16.98%
Holding current value
$220,928
Previous $405,000
34.57%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DCTH
# of Institutions
129Shares Held
13MCall Options Held
133KPut Options Held
159K-
Vanguard Group Inc Valley Forge, PA1.66MShares$14.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$6.14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT666KShares$5.95 Million0.29% of portfolio
-
State Street Corp Boston, MA621KShares$5.55 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$5.09 Million0.97% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $76.8M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...